V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008280 | 220003318 | 1.8 | 58.85 | Curative (C) | 2016-07-22 | 2016-07-23 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | Y | 220034189 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008281 | 220003319 | null | 73 | Palliative (P) | 2017-04-10 | 2017-04-11 | CARBOPLATIN | 1 | N | 220034195 | CARBOPLATIN |
| 220008282 | 220003320 | 1.78 | 86 | Palliative (P) | 2017-03-09 | 2017-03-09 | EOX | N | N | 220034197 | EOX |
| 220008283 | 220003320 | 1.7 | null | Curative (C) | 2015-08-02 | 2015-08-02 | ADE 8+3+5 | N | N | 220034197 | ADE |
| 220008284 | 220003320 | 1.61 | 73.1 | Curative (C) | 2017-07-20 | 2017-07-20 | Cisplatin + Radiotherapy | 2 | N | 220034197 | CISPLATIN + RT |
| 220008285 | 220003320 | 1.65 | 54.8 | Not known (9) | null | 2014-11-07 | Cytarabine High Dose | 02 | N | 220034197 | CYTARABINE HIGH DOSE |
| 220008286 | 220003320 | 1.6 | 80.9 | Palliative (P) | 2014-10-05 | 2014-10-08 | Carboplatin AUC 6 - 10 | N | N | 220034197 | CARBOPLATIN |
| 220008287 | 220003320 | null | 97.9 | Curative (C) | 2016-12-09 | 2016-12-09 | Cytarabine High Dose | N | Y | 220034197 | CYTARABINE HIGH DOSE |
| 220008288 | 220003320 | 1.55 | 102.5 | Adjuvant (A) | null | 2014-01-24 | Cisplatin 100 + RT(H&N) 1 day | N | N | 220034197 | CISPLATIN + RT |
| 220008289 | 220003320 | null | 56 | Curative (C) | 2017-09-22 | 2017-11-20 | Rituximab | N | N | 220034197 | RAVVA TRIAL |
| 220008290 | 220003320 | 1.8 | 64 | Palliative (P) | 2013-05-20 | 2013-05-20 | CARBOPLATIN + ETOPOSIDE | N | N | 220034197 | CARBOPLATIN + ETOPOSIDE |
| 220008291 | 220003320 | null | 82 | Curative (C) | 2014-12-18 | 2014-12-18 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034197 | ADE |
| 220008292 | 220003320 | 1.57 | 68 | Curative (C) | null | 2015-01-14 | Cytarabine High Dose | N | N | 220034197 | CYTARABINE HIGH DOSE |
| 220008293 | 220003321 | 1.83 | null | Palliative (P) | 2014-03-17 | 2014-03-17 | Carboplatin + Etoposide IV 3 day | 2 | Y | 220034217 | CARBOPLATIN + ETOPOSIDE |
| 220008294 | 220003322 | 1.46 | 56.4 | Palliative (P) | 2016-06-30 | 2016-07-05 | Carboplatin + Etoposide iv&po | 99 | null | 220034218 | CARBOPLATIN + ETOPOSIDE |
| 220008296 | 220003324 | 1.73 | 58 | Palliative (P) | 2014-07-10 | 2014-07-10 | EOX | N | N | 220034222 | EOX |
| 220008297 | 220003325 | 1.51 | 54 | Palliative (P) | null | 2016-03-31 | EOX | 02 | N | 220034223 | EOX |
| 220008298 | 220003325 | 1.53 | 51.65 | Palliative (P) | 2018-04-20 | 2018-04-21 | Rituximab | 1 | N | 220034223 | RITUXIMAB |
| 220008300 | 220003327 | null | 13.4 | Not known (9) | 2016-11-24 | 2016-11-24 | Cytarabine High Dose | N | null | 220034228 | CYTARABINE HIGH DOSE |
| 220008301 | 220003328 | 0 | 84.1 | Palliative (P) | 2017-10-06 | 2017-10-23 | ECX | 2 | N | 220034235 | ECX |
| 220008302 | 220011832 | 1.75 | 60 | Curative (C) | null | 2014-06-17 | AML Int Guide ADE 10+3+5 (1) | N | null | 220034237 | ADE |
| 220008303 | 220011832 | null | 52 | Curative (C) | 2017-01-11 | 2017-01-13 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034237 | ADE |
| 220008305 | 220020471 | 1.68 | 76 | 1 | 2014-12-12 | 2014-12-12 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 220034243 | CISPLATIN + RT |
| 220008306 | 220020471 | 1.63 | 73 | Palliative (P) | 2013-08-17 | 2013-08-23 | PEMBROLIZUMAB | 02 | N | 220034243 | PEMBROLIZUMAB |
| 220008307 | 220020471 | null | 58 | Curative (C) | 2016-06-09 | 2016-06-09 | Cytarabine High Dose | N | null | 220034243 | CYTARABINE HIGH DOSE |
| 220008308 | 220020471 | 1.78 | null | Palliative (P) | 2013-07-28 | 2013-07-29 | EOX | N | N | 220034243 | EOX |
| 220008311 | 220003330 | null | 77.2 | null | 2015-07-12 | 2015-08-07 | PEMBROLIZUMAB | N | N | 220034252 | RAVVA TRIAL |
| 220008312 | 220003331 | null | 22 | Adjuvant (A) | 2013-09-02 | 2013-09-02 | EOX | N | null | 220034254 | EOX |
| 220008313 | 220011834 | 1.7 | null | Palliative (P) | 2014-09-01 | 2014-09-21 | EOX | N | N | 220034255 | EOX |
| 220008314 | 220011834 | 1.76 | 104.7 | Palliative (P) | 2015-09-16 | 2015-09-17 | Carboplatin AUC 2 - 5 | 2 | N | 220034255 | CARBOPLATIN |
| 220008315 | 220003332 | 1.56 | 80 | Curative (C) | 2014-08-22 | 2014-08-22 | FLAG | N | N | 220034259 | FLAG |
| 220008316 | 220003333 | 1.74 | 78.4 | Palliative (P) | 2013-02-28 | 2013-03-24 | EOX | 2 | N | 220034260 | EOX |
| 220008317 | 220003334 | null | 93.7 | Palliative (P) | null | 2017-03-15 | Capecitabine + Oxaliplatin 21day | N | N | 220034263 | CAPECITABINE + OXALIPLATIN |
| 220008318 | 220011835 | 1.57 | 62 | Palliative (P) | 2014-08-08 | 2014-08-08 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 220034265 | RITUXIMAB |
| 220008319 | 220011835 | null | null | Palliative (P) | 2017-04-14 | 2017-04-14 | EOX | N | N | 220034265 | EOX |
| 220008320 | 220011835 | null | 89.4 | Palliative (P) | 2017-06-13 | 2017-06-27 | EOX | null | null | 220034265 | EOX |
| 220008321 | 220011835 | 1.65 | 55.4 | Palliative (P) | 2015-10-11 | 2015-10-18 | Rituximab | N | N | 220034265 | GEMCITABINE |
| 220008322 | 220021310 | 0 | 74.9 | Curative (C) | 2014-09-12 | 2014-09-12 | Cisplatin 100 + RT(H&N) 1 day | N | N | 220034270 | CISPLATIN + RT |
| 220008323 | 220021310 | 1.52 | null | Curative (C) | 2014-11-01 | 2014-11-02 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034270 | ADE |
| 220008324 | 220021310 | 1.55 | 66 | Curative (C) | 2016-04-02 | 2016-04-02 | CISPLATIN + RT | 2 | N | 220034270 | CISPLATIN + RT |
| 220008325 | 220021310 | 1.55 | 65 | Curative (C) | 2017-03-10 | 2017-03-14 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034270 | ADE |
| 220008326 | 220021310 | 1.55 | 66.8 | Curative (C) | 2016-09-26 | 2016-10-18 | Cisplatin 100 + RT(H&N) 1 day | N | N | 220034270 | CISPLATIN + RT |
| 220008327 | 220022293 | 1.87 | 76 | Curative (C) | 2015-06-06 | 2015-06-20 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220034282 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008328 | 220003335 | null | 78.4 | Curative (C) | 2016-05-21 | 2016-05-21 | Cytarabine High Dose | N | Y | 220034283 | CYTARABINE HIGH DOSE |
| 220008329 | 220003336 | null | 57.1 | Curative (C) | 2013-08-04 | 2013-08-04 | Cytarabine High Dose | N | N | 220034284 | CYTARABINE HIGH DOSE |
| 220008330 | 220003337 | 1.66 | 72 | Palliative (P) | 2013-11-28 | 2013-11-29 | EOX | N | N | 220034286 | EOX |
| 220008331 | 220003337 | 1.7 | 56 | Curative (C) | 2013-11-08 | 2013-11-08 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034286 | ADE |
| 220008332 | 220003337 | 0 | 53.4 | Palliative (P) | 2014-08-19 | 2014-08-20 | CARBOPLATIN | N | N | 220034286 | CARBOPLATIN |
| 220008334 | 220003338 | null | 56.3 | Disease modification (D) | null | 2013-07-31 | RAVVA TRIAL | 02 | N | 220034291 | RAVVA TRIAL |
| 220008335 | 220003339 | 1.55 | 76 | Palliative (P) | 2013-07-12 | 2013-07-12 | Carboplatin + Etoposide iv&po | N | N | 220034294 | CARBOPLATIN + ETOPOSIDE |